查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2011904

膠原蛋白蛋白胜肽市場：依原料、形態、應用及通路分類－2026-2032年全球市場預測

Collagen Peptides Market by Source, Form, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，膠原蛋白肽市場價值將達到 8.9413 億美元，到 2026 年將成長至 9.4447 億美元，到 2032 年將達到 13.5155 億美元，年複合成長率為 6.07%。

主要市場統計數據
基準年 2025 8.9413億美元
預計年份：2026年 9.4447億美元
預測年份 2032 1,351,550,000 美元
複合年成長率 (%) 6.07%

這是一本權威的入門書籍，系統地說明了膠原蛋白肽的科學基礎、市場重要性、消費者需求因素以及為高階主管提供的策略見解。

本篇概要闡述了膠原蛋白肽在科學證據、產品創新和商業策略這三大相互關聯的領域中的定位。膠原蛋白胜肽已從一種特殊的原料發展成為用途廣泛的成分，應用於從營養保健品和化妝品到機能性食品和特定藥物等眾多領域。其生物利用度和生化特性（包括胺基酸組成）是其預期功效的基礎，並推動了對萃取、純化和製劑技術的投資。

我們將檢驗透過採購創新、先進加工技術、監管變革和不斷變化的消費者健康需求，正在重塑膠原蛋白肽的變革性變化。

膠原蛋白肽產業正經歷一場根本性的變革，其驅動力包括創新、監管改革和採購模式的轉變。萃取方法和加工技術的最新進展提高了產品的一致性，並拓寬了可用原料的範圍。這使得製造商能夠在最佳化產品功能的同時，解決過敏原和可追溯性問題。同時，供應鏈中的相關人員也積極應對日益嚴格的永續性、可追溯性和道德採購審查，加速對認證、上游工程可追溯系統和供應商夥伴關係的投資。

評估近期美國關稅政策變化對膠原蛋白肽進口、供應鏈韌性、籌資策略和生產的累積影響。

美國關稅政策的變化正在為膠原蛋白肽供應鏈創造一個更複雜的貿易環境，促使企業重新評估採購和分銷策略。關稅調整正在影響採購時機、不同地區供應商的相對競爭力，以及在國內採購（回流生產）和繼續依賴全球供應商之間的決策。為此，採購團隊正在拓展供應商組合，增加關鍵地點的庫存緩衝，並將供應商認證範圍擴大到傳統網路以外的地區。

細分市場分析顯示供應商選擇、產品形式、通路策略和應用重點如何影響市場定位、創新和買家吸引力。

細分市場分析提供了一個系統性的觀點，幫助我們了解技術能力與商業性需求之間的交會點，揭示每種原料、形態、通路和應用的不同機會領域。依照原料（牛、魚貝類、植物、豬肉、禽肉）進行評估時，每種原料都具有獨特的屬性，例如胺基酸組成、致敏性、文化接受度和永續性認知，這些屬性會影響不同客戶群體和管理體制下的偏好。原料的這些差異也會影響上游供應鏈的複雜性、可追溯性要求以及加工過程中的資本密集度。

區域分析揭示了美洲、歐洲、中東和非洲以及亞太地區不同的需求促進因素、供應管道和監管環境。

區域趨勢造就了差異化的競爭環境，價值鏈、法律規範和消費者期望各不相同。在美洲，消費者對健康和美容產品的濃厚興趣推動了需求成長，這得益於其強大的零售和直銷系統。供應商需要考慮可追溯性以及是否符合食品和膳食補充劑法規。歐洲、中東和非洲地區（EMEA）的監管環境較為分散，對原料的接受度不一，高度重視永續性。因此，供應商和品牌需要採用區域特定的認證和傳播策略。在亞太地區，市場成熟度因國家而異。一些市場優先考慮接受傳統原料和在地採購，而其他市場則正在迅速轉向優質化和原料創新。

為了明確市場定位和優先領域，我們概述了競爭格局，包括產業內各公司的策略性舉措、產品組合、合作夥伴關係和研發投資。

一項聚焦競爭對手行為和企業策略的研究揭示了膠原蛋白肽市場中領導企業與追隨者之間的差異因素。競爭對手採取的舉措，例如拓展上游工程夥伴關係、進行有針對性的收購、投資專有加工技術以及實施認證採購計劃，都表明了他們致力於加強對原料採購和產品品質一致性的控制。在產品層面，各公司正透過配方科學、增值交付方式以及將胜肽與互補活性成分相結合的組合產品來實現差異化，這些組合產品旨在改善皮膚、關節或提升運動表現。

為領導企業提供切實可行的建議，以增強採購韌性、加速產品創新、最佳化管道並提高合應對力。

產業領導者應優先採取一系列切實可行的舉措，以增強韌性並實現差異化。首先，透過選擇替代供應商和投資數位化追溯工具，加強供應商多元化和可追溯性。這有助於降低單一來源風險，並為可信的永續性聲明提供支持。其次，透過針對性的研發項目加速產品創新，重點在於臨床檢驗、最佳化感官評估以及與常用給藥方式的兼容性。這有助於在滿足消費者對產品功效期望的同時，實現高階定位。

透明的調查方法，說明了資料收集、主要和次要來源、檢驗程序以及支持見解的分析框架。

本分析整合了透過混合調查方法收集的證據，該方法結合了與關鍵相關人員的對話、系統的二手資料研究和嚴格的檢驗。主要資訊來源包括對採購經理、研發負責人、品質保證專家和銷售管道合作夥伴的訪談，以了解實際限制和策略意圖。二手資訊來源則利用技術文獻、監管文件和公開的企業資訊披露，將主要研究結果置於更廣泛的行業趨勢背景下進行分析。

透過整合技術、商業性和監管方面的見解，我們為行業相關人員確定策略挑戰和前瞻性優先事項。

這項綜合分析匯集了技術、商業性和監管方面的洞見，提出了一系列連貫的策略挑戰。關鍵主題包括：品牌故事中可追溯性和永續性的重要性；配方和形態創新對消費者接受度的重要性；以及面對政策和貿易變化時供應鏈敏捷性的必要性。這些優先事項共同指向一個未來：那些將科學嚴謹性、供應鏈透明度和以客戶為中心的產品設計相結合的公司，將實現永續的差異化。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：膠原蛋白蛋白胜肽市場：依來源分類

  • 源自牛
  • 海洋來源
  • 植物
  • 豬肉衍生品
  • 家禽

第9章：膠原蛋白肽市場：依形式分類

  • 膠囊和片劑
  • 凝膠
  • 液體
  • 粉末

第10章：膠原蛋白肽市場：依應用領域分類

  • 動物飼料
  • 美容及個人護理
  • 營養補充品
  • 機能性食品和飲料
  • 製藥
  • 運動營養

第11章：膠原蛋白肽市場：按分銷管道分類

  • 離線
  • 線上

第12章膠原蛋白蛋白胜肽市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章膠原蛋白肽市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章膠原蛋白蛋白胜肽市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國膠原蛋白基質市場

第16章：中國膠原蛋白肽市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Advanced BioMatrix Inc
  • Amicogen Inc
  • BioCell Technology LLC
  • Collagen Solutions Plc
  • Darling Ingredients Inc
  • Ewald Gelatine GmbH
  • Foodmate Co Ltd
  • GELITA AG
  • Gelnex
  • Great Lakes Gelatin Company
  • Holista Colltech
  • Italgelatine SpA
  • Junca Gelatines SL
  • Lapi Gelatine SpA
  • Nippi Inc
  • Nitta Gelatin Inc
  • Norland Products Inc
  • PB Leiner
  • Rousselot
  • Tessenderlo Group
  • Thai Union Group
  • Titan Biotech Ltd
  • Viscofan DE GmbH
  • Vital Proteins LLC
  • Weishardt
Product Code: MRR-43539E5D2B6B

The Collagen Peptides Market was valued at USD 894.13 million in 2025 and is projected to grow to USD 944.47 million in 2026, with a CAGR of 6.07%, reaching USD 1,351.55 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 894.13 million
Estimated Year [2026] USD 944.47 million
Forecast Year [2032] USD 1,351.55 million
CAGR (%) 6.07%

An authoritative introduction framing collagen peptides' scientific basis, market relevance, consumer demand drivers and strategic insight for leaders

This executive introduction situates collagen peptides within the intersecting domains of scientific evidence, product innovation and commercial strategy. Collagen peptides have evolved from a specialized ingredient category to a cross-sector input with applications spanning nutraceuticals, beauty formulations, functional foods and targeted pharmaceutical uses. The biochemical properties, including bioavailability and amino acid profiles, underpin their perceived benefits and have catalyzed investment in extraction, purification and formulation techniques.

Consequently, stakeholders across supply chains-from raw material suppliers and contract manufacturers to brand owners and distribution partners-are reevaluating positioning and capability sets. In addition, consumers are increasingly informed by clinical studies as well as lifestyle trends, prompting brands to communicate efficacy with evidence while differentiating on source, sustainability and sensory attributes. Taken together, this introduction frames the subsequent analysis by clarifying the scientific basis, commercial levers and shifting consumer priorities that are central to strategic decision-making.

Examining transformative shifts reshaping collagen peptides through sourcing innovation, advanced processing, regulatory change and shifting consumer health needs

Industry dynamics for collagen peptides are undergoing fundamental transformation driven by innovation, regulatory reappraisal and shifting procurement logic. Recent advances in extraction methods and processing technologies have raised product consistency and broadened the range of usable raw inputs, enabling manufacturers to optimize functional attributes while addressing allergen and traceability concerns. At the same time, supply chain actors are responding to increased scrutiny on sustainability, traceability and ethical sourcing, prompting investments in certification, upstream traceability systems and supplier partnerships.

Moreover, regulatory attention to ingredient provenance and labeling imposes new compliance expectations that influence route-to-market choices and formulation claims. Parallel to these technical and regulatory shifts, consumer demand is evolving: wellness-oriented consumers now prioritize demonstrable benefits, clean-label compositions and credible sustainability narratives. For companies that align sourcing, R&D and brand communication with these multi-dimensional shifts, there is an opportunity to capture differentiated value and to accelerate cross-category adoption of collagen peptide-based offerings.

Evaluating the cumulative impact of recent U.S. tariff policy changes on collagen peptide imports, supply chain resilience, sourcing strategies and manufacturing

Changes to United States tariff policies have created a more complex trade environment for collagen peptide supply chains, prompting reassessments of sourcing and distribution strategies. Tariff adjustments influence procurement timing, the relative competitiveness of different supplier geographies, and the calculus around onshoring versus continued reliance on global suppliers. In response, procurement teams are diversifying supplier portfolios, increasing inventory buffers in critical nodes, and expanding supplier qualification to include nontraditional geographies.

In practical terms, importers and manufacturers are reallocating operational attention toward freight optimization, tariff engineering and tariff classification reviews to minimize unintended cost and compliance impacts. At the same time, commercial teams are revisiting pricing strategies and contractual clauses to better allocate and communicate risk. Taken together, these responses have reinforced the importance of supply chain visibility, flexible sourcing playbooks and regulatory expertise as pillars of resilience in an era of shifting trade policy.

Segmentation analysis showing how source selection, product form, channel strategy and application focus shape market position, innovation and buyer appeal

Segmentation analysis provides a structured lens for understanding where technical capabilities and commercial demand intersect, and it reveals opportunity zones that vary by source, form, channel and application. When evaluated by source-Bovine, Marine, Plant, Porcine and Poultry-each input brings distinct attributes related to amino acid profile, allergenicity, cultural acceptability and sustainability perception, which in turn drive preference among different customer cohorts and regulatory regimes. These source differences also affect upstream supply chain complexity, traceability requirements and the capital intensity of processing.

Looking at product form-Capsule & Tablet, Gel, Liquid and Powder-format choices reflect end-use constraints, consumer convenience expectations and formulation compatibility. Capsules and tablets cater to supplement channels with standardized dosing, gels address topical or confectionery uses, liquids serve ready-to-drink applications, and powders offer flexibility for functional foods and ingredient blending. Distribution channel segmentation between Offline and Online underlines how purchase behavior and regulatory disclosure expectations differ across retail footprints; offline channels rely on sensory interaction and in-store expertise, whereas online channels emphasize digital claims, reviews and delivery logistics. Finally, by application-Animal Feed, Beauty & Personal Care, Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals and Sports Nutrition-the functional requirements and regulatory pathways vary substantially, shaping R&D priorities and commercialization strategies. Synthesizing these segmentation dimensions highlights that strategic differentiation often requires coordinated choices across source, form, channel and application to deliver coherent and defensible value propositions.

Regional analysis exposing varied demand drivers, supply pathways and regulatory landscapes across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional dynamics create differentiated competitive environments where value chains, regulatory frameworks and consumer expectations diverge. In the Americas, demand tends to be driven by strong consumer interest in wellness and beauty applications, supported by robust retail and direct-to-consumer infrastructures; supply-side considerations focus on traceability and compliance with food and supplement regulations. Europe, Middle East & Africa presents a fragmented regulatory landscape with varied acceptance of source types and a strong emphasis on sustainability credentials, which prompts suppliers and brands to adopt region-specific certification and communication strategies. Asia-Pacific exhibits a broad spectrum of maturity across countries: some markets emphasize traditional ingredient acceptance and local sourcing, while others move rapidly toward premiumization and ingredient innovation.

These regional distinctions affect strategic priorities for investors and operators. For example, regulatory labeling, import controls and culturally informed source preferences require tailored go-to-market approaches, while distribution strategies must reflect local retail formats and e-commerce penetration. Consequently, companies seeking cross-regional presence need to align product formulations, claims and supply chain practices to meet the diverse expectations and compliance requirements found across the Americas, Europe, Middle East & Africa, and Asia-Pacific.

Competitive overview of strategic moves, portfolios, collaborations and R&D investments among industry players to clarify market positioning and priority areas

A focused study of competitor behaviors and corporate strategies reveals the levers that differentiate leaders from followers in the collagen peptide space. Competitive actions such as expanded upstream partnerships, targeted acquisitions, investments in proprietary processing technology and the introduction of certified sourcing programs indicate a push toward greater control over raw material inputs and product consistency. At the product level, firms are distinguishing themselves through formulation science, value-added delivery formats and bundled offers that combine peptides with complementary actives for skin, joint or performance outcomes.

Collaboration is also a notable trend: strategic partnerships between ingredient suppliers and consumer brands accelerate product innovation and market validation, while R&D investments that prioritize clinical substantiation strengthen claims and help navigate evolving regulatory expectations. From a strategic perspective, companies that integrate supply chain controls with differentiated technical capabilities and clear go-to-market narratives are better positioned to capture premium positions and to defend against commoditization pressures.

Practical recommendations for leaders to bolster sourcing resilience, accelerate product innovation, optimize channels and improve regulatory readiness

Industry leaders should prioritize a set of practical actions that improve resilience and unlock differentiation. First, strengthen supplier diversification and traceability by qualifying alternative sources and investing in digital traceability tools; this reduces exposure to single-origin risks and supports credible sustainability claims. Second, accelerate product innovation through targeted R&D programs that emphasize clinical validation, sensory optimization and compatibility with popular delivery formats to meet consumer efficacy expectations while enabling premium positioning.

Third, optimize channel strategies by tailoring packaging, claims and fulfillment approaches to the specific dynamics of offline retail and online commerce. Fourth, enhance regulatory readiness by building internal expertise on classification, labeling and cross-border compliance to avoid costly relabeling or market delays. Finally, operationalize these priorities through cross-functional governance that aligns procurement, R&D, regulatory and commercial teams, ensuring that strategic initiatives translate into executable roadmaps and measurable outcomes.

Transparent research methodology describing data collection, primary and secondary sources, validation steps and analytical frameworks to support insights

The analysis synthesizes evidence gathered through a blended methodology that combines primary stakeholder engagement with structured secondary research and rigorous validation. Primary inputs include interviews with procurement leaders, R&D scientists, quality assurance professionals and channel partners to capture real-world constraints and strategic intent. Secondary inputs draw on technical literature, regulatory documents and publicly available corporate disclosures to contextualize primary observations within broader industry trends.

Analytical rigor was maintained through triangulation of sources, cross-checking qualitative insights against documentable actions and testing hypotheses with industry experts. Where applicable, scenario analysis was used to examine the implications of policy and supply-side events on procurement and product strategies. This methodological transparency supports confidence in the thematic findings and clarifies the evidentiary basis for the recommendations presented earlier.

Conclusive synthesis weaving technical, commercial and regulatory insights to define strategic imperatives and future-ready priorities for industry stakeholders

The synthesis consolidates technical, commercial and regulatory insights into a coherent set of strategic imperatives. Key themes include the centrality of source traceability and sustainability to brand narratives, the importance of formulation and format innovation for consumer adoption, and the need for supply chain agility in the face of policy and trade shifts. Collectively, these priorities point toward a future in which companies that integrate scientific rigor, supply chain transparency and customer-centric product design will achieve durable differentiation.

In closing, stakeholders should treat the described trends as directional signals that inform investment choices, partnership selection and capability building rather than as prescriptive answers. By aligning corporate strategy with the multi-dimensional drivers outlined in this synthesis-technical performance, regulatory compliance, consumer perception and regional specificity-organizations can convert insight into operational advantage and long-term resilience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Collagen Peptides Market, by Source

  • 8.1. Bovine
  • 8.2. Marine
  • 8.3. Plant
  • 8.4. Porcine
  • 8.5. Poultry

9. Collagen Peptides Market, by Form

  • 9.1. Capsule & Tablet
  • 9.2. Gel
  • 9.3. Liquid
  • 9.4. Powder

10. Collagen Peptides Market, by Application

  • 10.1. Animal Feed
  • 10.2. Beauty & Personal Care
  • 10.3. Dietary Supplements
  • 10.4. Functional Foods & Beverages
  • 10.5. Pharmaceuticals
  • 10.6. Sports Nutrition

11. Collagen Peptides Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Collagen Peptides Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Collagen Peptides Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Collagen Peptides Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Collagen Peptides Market

16. China Collagen Peptides Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Advanced BioMatrix Inc
  • 17.6. Amicogen Inc
  • 17.7. BioCell Technology LLC
  • 17.8. Collagen Solutions Plc
  • 17.9. Darling Ingredients Inc
  • 17.10. Ewald Gelatine GmbH
  • 17.11. Foodmate Co Ltd
  • 17.12. GELITA AG
  • 17.13. Gelnex
  • 17.14. Great Lakes Gelatin Company
  • 17.15. Holista Colltech
  • 17.16. Italgelatine S.p.A
  • 17.17. Junca Gelatines SL
  • 17.18. Lapi Gelatine S.p.A
  • 17.19. Nippi Inc
  • 17.20. Nitta Gelatin Inc
  • 17.21. Norland Products Inc
  • 17.22. PB Leiner
  • 17.23. Rousselot
  • 17.24. Tessenderlo Group
  • 17.25. Thai Union Group
  • 17.26. Titan Biotech Ltd
  • 17.27. Viscofan DE GmbH
  • 17.28. Vital Proteins LLC
  • 17.29. Weishardt

LIST OF FIGURES

  • FIGURE 1. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COLLAGEN PEPTIDES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL COLLAGEN PEPTIDES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES COLLAGEN PEPTIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA COLLAGEN PEPTIDES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY BOVINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY BOVINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY BOVINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY MARINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY MARINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY MARINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY PLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY PLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY PLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY PORCINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY PORCINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY PORCINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY CAPSULE & TABLET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY CAPSULE & TABLET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY CAPSULE & TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY BEAUTY & PERSONAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY BEAUTY & PERSONAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY BEAUTY & PERSONAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY DIETARY SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY DIETARY SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY FUNCTIONAL FOODS & BEVERAGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY FUNCTIONAL FOODS & BEVERAGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY FUNCTIONAL FOODS & BEVERAGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY SPORTS NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY SPORTS NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY SPORTS NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS COLLAGEN PEPTIDES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS COLLAGEN PEPTIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS COLLAGEN PEPTIDES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS COLLAGEN PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS COLLAGEN PEPTIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA COLLAGEN PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA COLLAGEN PEPTIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA COLLAGEN PEPTIDES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA COLLAGEN PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA COLLAGEN PEPTIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA COLLAGEN PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA COLLAGEN PEPTIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA COLLAGEN PEPTIDES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA COLLAGEN PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA COLLAGEN PEPTIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA COLLAGEN PEPTIDES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA COLLAGEN PEPTIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA COLLAGEN PEPTIDES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA COLLAGEN PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA COLLAGEN PEPTIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE COLLAGEN PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE COLLAGEN PEPTIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE COLLAGEN PEPTIDES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE COLLAGEN PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE COLLAGEN PEPTIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST COLLAGEN PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST COLLAGEN PEPTIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST COLLAGEN PEPTIDES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST COLLAGEN PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST COLLAGEN PEPTIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA COLLAGEN PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA COLLAGEN PEPTIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA COLLAGEN PEPTIDES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA COLLAGEN PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA COLLAGEN PEPTIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC COLLAGEN PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC COLLAGEN PEPTIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC COLLAGEN PEPTIDES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC COLLAGEN PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC COLLAGEN PEPTIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN COLLAGEN PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN COLLAGEN PEPTIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN COLLAGEN PEPTIDES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN COLLAGEN PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN COLLAGEN PEPTIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. GCC COLLAGEN PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GCC COLLAGEN PEPTIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 106. GCC COLLAGEN PEPTIDES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 107. GCC COLLAGEN PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. GCC COLLAGEN PEPTIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION COLLAGEN PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION COLLAGEN PEPTIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION COLLAGEN PEPTIDES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION COLLAGEN PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION COLLAGEN PEPTIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS COLLAGEN PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS COLLAGEN PEPTIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS COLLAGEN PEPTIDES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS COLLAGEN PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS COLLAGEN PEPTIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. G7 COLLAGEN PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. G7 COLLAGEN PEPTIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 121. G7 COLLAGEN PEPTIDES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 122. G7 COLLAGEN PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. G7 COLLAGEN PEPTIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. NATO COLLAGEN PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. NATO COLLAGEN PEPTIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 126. NATO COLLAGEN PEPTIDES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 127. NATO COLLAGEN PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. NATO COLLAGEN PEPTIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL COLLAGEN PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. UNITED STATES COLLAGEN PEPTIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. UNITED STATES COLLAGEN PEPTIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 132. UNITED STATES COLLAGEN PEPTIDES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES COLLAGEN PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES COLLAGEN PEPTIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. CHINA COLLAGEN PEPTIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 136. CHINA COLLAGEN PEPTIDES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 137. CHINA COLLAGEN PEPTIDES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 138. CHINA COLLAGEN PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA COLLAGEN PEPTIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)